Litcius/Paper detail

Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial

Nick de Jonge, Jonne J. Sikkens, Sonja Zweegman, Aart Beeker, Paula Ypma, A H E Herbers, W. L. E. Vasmel, Arne de Kreuk, J.L. Coenen, Birgit I. Lissenberg‐Witte, Mark H.H. Kramer, Michiel A. van Agtmael, Jeroen J. W. M. Janssen

2022The Lancet Haematology47 citationsDOIOpen Access PDF

Topics & Concepts

MedicineFebrile neutropeniaNeutropeniaInternal medicineDiscontinuationSeptic shockRegimenSurgeryClinical endpointChemotherapy regimenRandomized controlled trialSepsisChemotherapyHematological disorders and diagnosticsNeutropenia and Cancer InfectionsSepsis Diagnosis and Treatment